Good morning, In this month’s Newsletter, we highlight the recent significant achievements made in our technology development, as Archer entered a new era of growth as a pure-play deep technology company.
Archer recently shared a Corporate Presentation that better reflects the Company’s focus, strategic priorities, and activities as a pure-play deep technology company having completed a A$25 million capital raise (before costs), sold the Company’s mineral exploration business, and changed GICS code to ‘Semiconductors’.
The funds raised ensure that we have the capability to hire highly skilled staff and access the advanced labs required to grow the Company. We have been ultra-focused on strengthening and expanding semiconductor chip fabrication capabilities, as this is one of the biggest challenges to potential commercialisation of our technologies, including the development of Archer’s biochip.
We announced significant technical progress with the 12CQ quantum computing chip and Archer’s biochip shortly after COVID-19 restrictions lifting in NSW. We expect to make further progress with both technologies as travel restrictions continue to ease, and I look forward to updating you on our developments.
Due to the proposed opening of the South Australian borders, Archer’s new Non-Executive Director Bernadette Harkin and I will now be attending the Company’s Annual General Meeting (AGM) in person. Shareholders who cannot attend the AGM are encouraged to appoint a proxy ahead of the AGM to cast their vote at the AGM.
I want to thank shareholders for their continued support; it has been a special year at Archer, and I am looking forward to reconnecting with you at future events in-person, starting with this year’s AGM.
Dr Mohammad Choucair, FRACI FRSN GAICD
Chief Executive Officer
Archer Materials Limited (ASX:AXE)